<codeBook xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="ddi:codebook:2_5 http://www.ddialliance.org/Specification/DDI-Codebook/2.5/XMLSchema/codebook.xsd" xmlns="ddi:codebook:2_5">
  <docDscr>
    <citation>
      <titlStmt>
        <titl xml:lang="sv">Undetected cancer in clinical prostate biopsies</titl>
        <parTitl xml:lang="en">Undetected cancer in clinical prostate biopsies</parTitl>
        <IDNo agency="SND">2024-144-1</IDNo>
        <IDNo agency="DOI">https://doi.org/10.57804/epa0-8v59</IDNo>
      </titlStmt>
      <prodStmt>
        <producer xml:lang="en" abbr="SND">Swedish National Data Service</producer>
        <producer xml:lang="sv" abbr="SND">Svensk nationell datatjänst</producer>
      </prodStmt>
      <holdings URI="https://doi.org/10.57804/epa0-8v59">Landing page</holdings>
    </citation>
  </docDscr>
  <stdyDscr>
    <citation>
      <titlStmt>
        <titl xml:lang="sv">Undetected cancer in clinical prostate biopsies</titl>
        <parTitl xml:lang="en">Undetected cancer in clinical prostate biopsies</parTitl>
        <IDNo agency="SND">2024-144-1</IDNo>
        <IDNo agency="DOI">https://doi.org/10.57804/epa0-8v59</IDNo>
      </titlStmt>
      <rspStmt>
        <AuthEnty xml:lang="en" affiliation="Department of Information Technology, Uppsala University">Chelebian, Eduard</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Institutionen för informationsteknologi, Uppsala universitet">Chelebian, Eduard</AuthEnty>
        <AuthEnty xml:lang="en" affiliation="Department of Information Technology, Uppsala University">Wählby, Carolina</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Institutionen för informationsteknologi, Uppsala universitet">Wählby, Carolina</AuthEnty>
        <AuthEnty xml:lang="en" affiliation="Department of Medical Biosciences, Umeå University">Bergh, Anders</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Institutionen för medicinsk biovetenskap, Umeå universitet">Bergh, Anders</AuthEnty>
      </rspStmt>
      <prodStmt>
        <grantNo xml:lang="en" agency="Swedish Cancer Society">21-1856</grantNo>
        <grantNo xml:lang="en" agency="European Research Council">CoG 682810</grantNo>
      </prodStmt>
      <distStmt>
        <distrbtr xml:lang="en" abbr="SND" URI="https://snd.se">Swedish National Data Service</distrbtr>
        <distrbtr xml:lang="sv" abbr="SND" URI="https://snd.se">Svensk nationell datatjänst</distrbtr>
        <distDate xml:lang="en" date="2024-06-17" />
      </distStmt>
      <verStmt>
        <version elementVersion="1" elementVersionDate="2024-06-17" />
      </verStmt>
      <holdings URI="https://doi.org/10.57804/epa0-8v59">Landing page</holdings>
    </citation>
    <stdyInfo>
      <subject>
        <keyword xml:lang="en" vocab="ELSST" vocabURI="https://elsst.cessda.eu/id/6/88613e8a-3055-4ff2-84c2-750a111c4372">PATHOLOGY</keyword>
        <keyword xml:lang="sv" vocab="ELSST" vocabURI="https://elsst.cessda.eu/id/6/88613e8a-3055-4ff2-84c2-750a111c4372">PATOLOGI</keyword>
        <keyword xml:lang="en" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D006652">Histological Techniques</keyword>
        <keyword xml:lang="sv" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D006652">Histologiska tekniker</keyword>
        <keyword xml:lang="en" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D007091">Image Processing, Computer-Assisted</keyword>
        <keyword xml:lang="sv" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D007091">Datorstödd bildbehandling</keyword>
        <keyword xml:lang="en" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D009370">Neoplasms by Histologic Type</keyword>
        <keyword xml:lang="sv" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D009370">Tumörer, histologisk typ</keyword>
        <keyword xml:lang="en" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D013194">Staining and Labeling</keyword>
        <keyword xml:lang="sv" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D013194">Färgning och märkning</keyword>
        <keyword xml:lang="en" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D017430">Prostate-Specific Antigen</keyword>
        <keyword xml:lang="sv" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D017430">Prostataspecifikt antigen</keyword>
        <keyword xml:lang="en" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D019295">Computational Biology</keyword>
        <keyword xml:lang="sv" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D019295">Beräkningsbiologi</keyword>
        <keyword xml:lang="en" vocab="ICD-10" vocabURI="https://icd.who.int/browse10/2019/en#/C61">Malignant neoplasm of prostate</keyword>
        <keyword xml:lang="sv" vocab="ICD-10" vocabURI="https://icd.who.int/browse10/2019/en#/C61">Malign tumör i prostata</keyword>
        <keyword xml:lang="en" vocab="ICD-10" vocabURI="https://icd.who.int/browse10/2019/en#/D29.1">Benign neoplasm: Prostate</keyword>
        <keyword xml:lang="sv" vocab="ICD-10" vocabURI="https://icd.who.int/browse10/2019/en#/D29.1">Benign tumör i prostata</keyword>
        <keyword xml:lang="en" vocab="ELSST" vocabURI="https://elsst.cessda.eu/id/6/3413ed2c-aab5-4565-96f0-77b444c05ad8">PROSTATE CANCER SCREENING</keyword>
        <keyword xml:lang="sv" vocab="ELSST" vocabURI="https://elsst.cessda.eu/id/6/3413ed2c-aab5-4565-96f0-77b444c05ad8">SCREENING FÖR PROSTATACANCER</keyword>
        <topcClas xml:lang="en" vocab="CESSDA Topic Classification" vocabURI="https://vocabularies.cessda.eu/vocabulary/TopicClassification?code=ScienceAndTechnology">SCIENCE AND TECHNOLOGY</topcClas>
        <topcClas xml:lang="sv" vocab="CESSDA Topic Classification" vocabURI="https://vocabularies.cessda.eu/vocabulary/TopicClassification?code=ScienceAndTechnology">VETENSKAP OCH TEKNOLOGI</topcClas>
        <topcClas xml:lang="en" vocab="CESSDA Topic Classification" vocabURI="https://vocabularies.cessda.eu/vocabulary/TopicClassification?code=ScienceAndTechnology.InformationTechnology">Information technology</topcClas>
        <topcClas xml:lang="sv" vocab="CESSDA Topic Classification" vocabURI="https://vocabularies.cessda.eu/vocabulary/TopicClassification?code=ScienceAndTechnology.InformationTechnology">Informationsteknik</topcClas>
      </subject>
      <abstract xml:lang="en" contentType="abstract">This dataset comprises digitized benign prostate hematoxilyn and eosin (H&amp;E) biopsies from men with raised prostate-specific antigen (PSA) values. The biopsies were systematically taken from different locations in the prostate and were not guided by magnetic resonance imaging (MRI). The dataset includes paired samples from patients with comparable age and PSA levels, all initially diagnosed as benign but with different outcomes upon subsequent follow-ups and re-biopsies. While some patients remained cancer-free during eight years of follow-up, others were diagnosed with prostate cancer within the subsequent 30 months of follow-up. 
The final processed dataset includes 213 patients from northern Sweden, resulting in a total of 587 H&amp;E prostate needle biopsies. Among these, 125 control patients with 333 biopsies exhibited no cancer development in eight years following the initial diagnosis. Conversely, 88 case patients with 254 biopsies were diagnosed with prostate cancer of various ISUP grades within the 30 months following the initial diagnosis. Each case patient is accompanied by one to three control patients, paired for similar age, PSA value and year of diagnosis. 
Patients were anonymized by assigning random case IDs and MRXS image files were anonymized by using the module in https://github.com/bgilbert/anonymize-slide.</abstract>
      <abstract xml:lang="sv" contentType="abstract">Datasetet består av digitiserade godartade prostata H&amp;E-biopsier från män med förhöjda PSA-värden. För mer information, se beskrivning på engelska:

This dataset comprises digitized benign prostate hematoxilyn and eosin (H&amp;E) biopsies from men with raised prostate-specific antigen (PSA) values. The biopsies were systematically taken from different locations in the prostate and were not guided by magnetic resonance imaging (MRI). The dataset includes paired samples from patients with comparable age and PSA levels, all initially diagnosed as benign but with different outcomes upon subsequent follow-ups and re-biopsies. While some patients remained cancer-free during eight years of follow-up, others were diagnosed with prostate cancer within the subsequent 30 months of follow-up. 
The final processed dataset includes 213 patients from northern Sweden, resulting in a total of 587 H&amp;E prostate needle biopsies. Among these, 125 control patients with 333 biopsies exhibited no cancer development in eight years following the initial diagnosis. Conversely, 88 case patients with 254 biopsies were diagnosed with PCa of various ISUP grades within the 30 months following the initial diagnosis. Each case patient is accompanied by one to three control patients, paired for similar age, PSA value and year of diagnosis. 
Patients were anonymized by assigning random case IDs and MRXS image files were anonymized by using the module in https://github.com/bgilbert/anonymize-slide.</abstract>
      <sumDscr>
        <anlyUnit xml:lang="en" unit="Individual">Individual<concept vocab="DDI Analysis Unit" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/AnalysisUnit/2.1.3?languageVersion=en-2.1.3">Individual</concept></anlyUnit>
        <anlyUnit xml:lang="sv" unit="Individ">Individ<concept vocab="DDI Analysis Unit" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/AnalysisUnit/2.1.3?languageVersion=sv-2.1.3">Individ</concept></anlyUnit>
        <universe xml:lang="en">Anonymised men from northern Sweden with raised serum prostate-specific antigen (PSA), an initial benign diagnosis in prostate needle biopsies and with subsequent separation in diagnostic trajectories.</universe>
        <universe xml:lang="sv">Anonymised men from northern Sweden with raised serum prostate-specific antigen (PSA), an initial benign diagnosis in prostate needle biopsies and with subsequent separation in diagnostic trajectories.</universe>
        <dataKind xml:lang="en">Still image</dataKind>
      </sumDscr>
    </stdyInfo>
    <method>
      <dataColl>
        <collMode xml:lang="en">Tissue slides scanned using scanners at Umeå University and processed at Uppsala University.<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=en-5.0.0">Tissue slides scanned using scanners at Umeå University and processed at Uppsala University.</concept></collMode>
        <collMode xml:lang="en">Registry extract and/or access to biobank sample<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=en-5.0.0">Registry extract and/or access to biobank sample</concept></collMode>
        <collMode xml:lang="sv">Registerutdrag och/eller tillgång till prov i biobank<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=sv-5.0.0">Registerutdrag och/eller tillgång till prov i biobank</concept></collMode>
      </dataColl>
    </method>
    <dataAccs>
      <useStmt>
        <restrctn xml:lang="en">Access to data through SND. Data are freely accessible.</restrctn>
        <restrctn xml:lang="sv">Åtkomst till data via SND. Data är fritt tillgängliga.</restrctn>
        <conditions elementVersion="info:eu-repo-Access-Terms vocabulary">openAccess</conditions>
      </useStmt>
    </dataAccs>
    <othrStdyMat />
  </stdyDscr>
</codeBook>